CLOSED. This funding call makes available up to £342k (£171k per year for up to 2 years) to support several projects that align best with Novel Therapies' strategy.
Internal GOSH and ICH applicants only.
Why is it important?
In this theme we will build our capacity to offer clinical trial options to children affected by rare and complex conditions who have limited treatment options. The NIHR Great Ormond Street Hospital Biomedical Research Centre Novel Therapies theme is offering this funding as part of its commitment to better understand disease progression and respond to treatments more effectively.
Who can apply?
How much money is available?
Where possible, ideas should centre on the following priorities from the Novel Therapies' strategy:
In November 2017 we announced our first funding call and are pleased to announce the successful applicants. After careful consideration, the panel selected to fund two projects:
|Principal Investigator||Project Title||Award|
|Dr Hannah Mitchison||Novel genetic therapies for motile cilia disease||£102,000|
|Dr Veronica Kinsler||Gene therapy for congenital melanocytic naevi||£107,000
|Professor Chris Clark||Fractional diffusion imaging as a biomarker for pathology in Duchenne Muscular Dystrophy||£86,000|
|Professor Francesco Muntoni||Developing microRNAs as biomarkers and therapeutic targets in children with spinal muscular atroph||£132,170|